Bacterial cocktail, spores counter recurrent C. diffMay 22, 2022Mixed TopicsIBD & Intestinal Disorders
IBD after age 60: More evidence antibiotics play a roleMay 17, 2022Mixed TopicsIBD & Intestinal Disorders
Noninvasive esophageal cancer screening approaches may reach more at-risk patientsMay 5, 2022GI Oncology
Probiotics of the future: Precision medicine and rational designMarch 24, 2022IBD & Intestinal Disorders
What’s the future of microbiome therapies in C. diff, cancer?March 24, 2022IBD & Intestinal DisordersGI Oncology
Two studies shed light on IBD treatment after anti-TNF failureMarch 7, 2022IBD & Intestinal Disorders
Artificial intelligence aids assessment of UC activity, remissionMarch 2, 2022IBD & Intestinal Disorders
Robust immune response after COVID-19 boosters in those with IBDMarch 2, 2022COVID-19 UpdatesIBD & Intestinal Disorders